Efficient Management of First line ALK-rearranged NSCLC

Speciality: Oncology


Speaker:

Dr B K | Smruti Senior Consultant Medical and Hemato Oncologist at Bombay Hospital and Medical Research Centre

Dr Abhishek Kakroo | Senior Consultant Medical and Hemato Oncologist at Hemato Oncology Clinic, Vedanta

Dr Jogamaya Pattnaik | Assistant Professor - Department of Medical Oncology, KIMS Hospital, Bhubaneswar

Description:

.A warm welcome to all the medical professionals in this interesting session on the efficient management of first-line ALK-rearranged NSCLC.

Efficient management of first-line ALK-rearranged NSCLC involves a multidisciplinary approach integrating targeted therapy, precision diagnostics, and regular monitoring. Early identification of ALK mutations through molecular testing allows for tailored treatment strategies, such as ALK inhibitors, to be initiated promptly, optimizing patient outcomes and minimizing disease progression. 

Close collaboration between oncologists, pathologists, and radiologists ensures comprehensive care delivery, facilitating timely adjustments to treatment plans based on individual patient responses and evolving disease dynamics.

Therefore, get an overall knowledge on the efficient management of first-line ALK rearranged NSCLC. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Obesity-related cancer rising among both younger and older adults worldwide, study finds

2.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

3.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

4.

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

5.

Patients with head and neck cancer who cannot receive cisplatin now have new hope.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot